Food, Health & Wellness News
-
FendX Advancing REPELWRAP(TM) Film with Dunmore by Conducting an Additional Pilot Manufacturing Run on Dunmore’s Commercial Manufacturing Line and Provides Corporate Update
April 23, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
FendX Announces Corporate Update
April 19, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
FendX Reminds Shareholders of Webinar on April 11, 2024 to Showcase Recent Achievements and Provides Corporate Update
April 8, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
FendX Announces Webinar on April 11, 2024 to Showcase Recent Achievements and Provides Corporate Update
April 3, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
FendX Technologies Inc. to Present at the Emerging Growth Conference on April 4, 2024
April 2, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
FendX Continues to Advance Optimization of REPELWRAP(TM) Film with Completion of Pilot Manufacturing Run on Dunmore’s Commercial Manufacturing Equipment and Provides Corporate Update
March 28, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
Voyageur Pharmaceuticals Ltd. Announces Private Placement
January 16, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (“Voyageur” or the “Company”), a provider of innovative…
-
Sage Potash Secures Permit Approvals for Exploration Program at Sage Plain Potash Project
January 8, 2024 (Source) — Sage Potash Corp. (“Sage Potash”, “Sage” or the “Company”) (TSXV: SAGE) (OTCQB: SGPTF) is…
-
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule
December 21, 2023 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative medical imaging…
-
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
December 21, 2023 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative…